INSMED Inc
Financial highlights
| Metric | FY December 31, 2025 | FY December 31, 2024 | FY December 31, 2023 | FY December 31, 2022 | FY December 31, 2021 |
|---|---|---|---|---|---|
| Revenue | $606.4M | $363.7M | $305.2M | $245.4M | $188.5M |
| Operating income | -$1.2B | -$878.3M | -$709.6M | -$457.3M | -$375.1M |
| Cost of revenue | $122.9M | $85.7M | $65.6M | $55.1M | $44.2M |
| Cash from operations | -$935.0M | -$683.9M | -$536.2M | -$400.4M | -$363.3M |
| Capital expenditure | $32.6M | $21.9M | $13.3M | $9.9M | $7.3M |
| Free cash flow | -$967.6M | -$705.8M | -$549.5M | -$410.3M | -$370.6M |
| Impairments | $0 | $0 | — | — | — |
| Total assets | $2.3B | $2.0B | $1.3B | $1.7B | $1.2B |
| Total liabilities | $1.5B | $1.7B | $1.7B | $1.6B | $833.0M |
Shares outstanding 216.8M · Free float 94.4%
Annual filing data through FY ended December 31, 2025; float as of July 12, 2026.